vs
Side-by-side financial comparison of AIM ImmunoTech Inc. (AIM) and QIAGEN N.V. (QGEN). Click either name above to swap in a different company.
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located ...
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.0K | — | ||
| Q3 25 | $26.0K | — | ||
| Q2 25 | $25.0K | — | ||
| Q1 25 | $16.0K | — | ||
| Q4 24 | $45.0K | — | ||
| Q3 24 | $35.0K | — | ||
| Q2 24 | $50.0K | — | ||
| Q1 24 | $40.0K | — |
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-3.3M | — | ||
| Q2 25 | $-2.8M | — | ||
| Q1 25 | $-3.7M | — | ||
| Q4 24 | $-6.0M | — | ||
| Q3 24 | $-3.7M | — | ||
| Q2 24 | $-1.8M | — | ||
| Q1 24 | $-5.8M | — |
| Q4 25 | -14057.1% | — | ||
| Q3 25 | -9411.5% | — | ||
| Q2 25 | -10584.0% | — | ||
| Q1 25 | -22618.8% | — | ||
| Q4 24 | -13011.1% | — | ||
| Q3 24 | -12825.7% | — | ||
| Q2 24 | -7388.0% | — | ||
| Q1 24 | -14335.0% | — |
| Q4 25 | -19881.0% | — | ||
| Q3 25 | -12630.8% | — | ||
| Q2 25 | -11176.0% | — | ||
| Q1 25 | -23156.3% | — | ||
| Q4 24 | -13260.0% | — | ||
| Q3 24 | -10571.4% | — | ||
| Q2 24 | -3672.0% | — | ||
| Q1 24 | -14542.5% | — |
| Q4 25 | $-6.46 | — | ||
| Q3 25 | $1.57 | — | ||
| Q2 25 | $-3.68 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $-21.80 | — | ||
| Q3 24 | $-6.00 | — | ||
| Q2 24 | $-3.00 | — | ||
| Q1 24 | $-0.12 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
